Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review

Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for the prevention and cure of blindness and different eye diseases. Alcon’s pipeline products are developed through collaboration with institutions, medical innovators, research advisors and academic thought leaders. The company has operations in the Americas, Europe, the Middle East, and Africa and Asia Pacific. Alcon is headquartered in Fribourg, Switzerland.

Alcon Inc Key Recent Developments

Feb 27,2024: Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
Sep 25,2023: Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
Sep 06,2023: Alcon Announces Its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
Aug 15,2023: Alcon Reports Second Quarter 2023 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Alcon Inc - Key Facts
Alcon Inc - Key Employees
Alcon Inc - Key Employee Biographies
Alcon Inc - Major Products and Services
Alcon Inc - History
Alcon Inc - Company Statement
Alcon Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Alcon Inc - Business Description
Business Segment: Surgical
Overview
Performance
Business Segment: Vision Care
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: United States
Performance
R&D Overview
Alcon Inc - Corporate Strategy
Alcon Inc - SWOT Analysis
SWOT Analysis - Overview
Alcon Inc - Strengths
Alcon Inc - Weaknesses
Alcon Inc - Opportunities
Alcon Inc - Threats
Alcon Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Alcon Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
Alcon Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
Alcon Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 27, 2024: Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023
Sep 25, 2023: Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
Sep 06, 2023: Alcon Announces Its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
May 05, 2023: Alcon Announces Results of 2023 Annual General Meeting
May 01, 2023: Alcon announces largest-ever scientific presence at ASCRS 2023 and expands image-guided connectivity
Feb 12, 2023: Alcon announces settlement of litigation related to femtosecond laser assisted cataract surgery devices
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Alcon Inc, Key Facts
Alcon Inc, Key Employees
Alcon Inc, Key Employee Biographies
Alcon Inc, Major Products and Services
Alcon Inc, History
Alcon Inc, Subsidiaries
Alcon Inc, Key Competitors
Alcon Inc, Ratios based on current share price
Alcon Inc, Annual Ratios
Alcon Inc, Annual Ratios (Cont...1)
Alcon Inc, Annual Ratios (Cont...2)
Alcon Inc, Interim Ratios
Alcon Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
Alcon Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
Alcon Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Alcon Inc, Performance Chart (2019 - 2023)
Alcon Inc, Ratio Charts
Alcon Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
Alcon Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings